Vishuo databases aim at targeted medical treatments

Singapore

WHEN conventional treatments such as surgery and chemotherapy failed to work for a lung-cancer patient after three years, he turned to Vishuo Biomedical for a course of treatment targeted at his particular gene profile.

The Singapore-based health-care technology company says that not only did the treatment take effect, the patient was well enough several months later to take a holiday in Tibet, where the high altitude makes thin, lower-oxygen air a norm.